{"id":205428,"name":"ADAPTIVE PHAGE THERAPEUTICS","slug":"adaptive-phage-therapeutics","state":"MD","country":"United States of America","description":"Life sciences company developing treatments for drug resistant bacteria.","totalSpending":80000,"filings":22,"yearlySpending":[{"year":2020,"income":80000},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":["HCR","MED"],"firms":["MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)"],"lobbyists":["JOHN MILNE","JEFFREY WIENER","ALLEN SHOFE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Defense, Dept of (DOD)"],"sampleDescriptions":["Promoting federal policies to develop therapeutics to combat drug resistant bacterial infections","Advocacy for federal funding related to the development of phage therapeutics to combat anti-microbial resistance","Advocacy for federal funding related to the development of phage therapeutics to combat anti-microbial resistance","Advocacy for federal funding related to the development of phage therapeutics to combat anti-microbial resistance"],"years":[2020,2021,2022,2023,2024,2025]}